Jan. 9th, 2009

joreth: (Nude Drawing)
Visit http://www.plannedparenthood.com/ for information about events in your local area:

January is Cervical Cancer Awareness month.  Come and learn about ways to protect yourself and loved ones.  Planned Parenthood of Greater Orlando is collaborating with the Orange County Library System to discuss information about Cervical Cancer and ways to prevent it.  Gardasil, the HPV Vaccine, will be highlighted as well as ways to get the vaccine for FREE!

This event is free and open to the public.  For your convenience, there will be four different informational sessions at various locations throughout the county.


 Saturday, January 10th: Eatonville Branch at 11:00am

 Saturday, January 10th: South Trail Branch at 2:30pm

 Tuesday, January 13th: Alafaya Branch at 6:30pm

 Wednesday, January 14th: Southeast Branch at 6:30pm


For more information, please feel free to call Lisa at 407-246-1788 ext. 113 or visit www.ocls.info


Visit the web address below to tell your friends about this.

joreth: (Bad Computer!)

"NEW YORK, Jan 9 (Reuters) - U.S. health regulators have again withheld approval for the use of Merck & Co Inc's (MRK.N) Gardasil cervical cancer vaccine by women aged 27 to 45, asking for longer-term clinical data, the drugmaker said on Friday.  The U.S. Food and Drug Administration recommended Merck submit data when a 48-month study on a test group has been completed. The agency also withheld approval in June on Merck's initial application that was based on data collected through an average of 24 months.


"Gardasil's efficacy drops sharply once females have been exposed to HPV and this is probably the genesis of the problem with the older female population that Merck has been pushing for in this new application," Sanford Bernstein analyst Tim Anderson said in a research note."


"In 2007, Merck released results of a study showing that Gardasil was effective at preventing infection by certain HPV strains in women up to age 45. The study showed a 91% reduction in cases of persistent infection, low-grade cervical abnormalities and pre-cancers, and external genital lesions caused by the four HPV strains, versus a placebo vaccine.

The study measured only incidents caused by the targeted HPV strains that weren't already present in women at the start of the study or during the dosing regimen. The vaccine is given in three doses over six months.

In comparison, an earlier study in females aged 16 to 23 showed Gardasil reduced these incidents by 96% versus placebo."


September 2017

3456 7 8 9
1011 12 13141516